These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7036330)

  • 1. Papillary necrosis in vitro: a scanning electron microscopic comparison of escherichia coli and Proteus mirabilis infection.
    Cohen MS; Davis CP; Baur PS; Warren MM
    Scan Electron Microsc; 1981; (Pt 3):65-72. PubMed ID: 7036330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning electron microscopic examinations of renal stones associated with urinary infections.
    Hirano S; Ohkawa M; Hisazumi H
    Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):293-300. PubMed ID: 3302428
    [No Abstract]   [Full Text] [Related]  

  • 3. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental bladder stone production by human uropathogenic bacteria].
    Arai Y; Takeuchi H; Tomoyoshi T
    Hinyokika Kiyo; 1997 Mar; 43(3):207-11. PubMed ID: 9127756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in murine peritonitis correlates with increased Escherichia coli adherence to the intestinal mucosa.
    Burch PT; Scott MJ; Wortz GN; Peyton JC; Cheadle WG
    Am Surg; 2004 Apr; 70(4):333-41. PubMed ID: 15098788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on the role of bacteria from urinary tract infections on the bladder carcinogenesis].
    Kaji S
    Fukuoka Igaku Zasshi; 1994 Oct; 85(10):294-308. PubMed ID: 7995611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
    Fraga M; Scavone P; Zunino P
    Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different binding specificities of P. mirabilis compared to E. coli.
    Lomberg H; Larsson P; Leffler H; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():37-42. PubMed ID: 6753134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LPS on epithelial integrity and bacterial uptake in the polarized human enterocyte-like cell line Caco-2.
    Wells CL; Jechorek RP; Olmsted SB; Erlandsen SL
    Circ Shock; 1993 Aug; 40(4):276-88. PubMed ID: 8375030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the pH and the urine infected by Escherichia coli and Proteus mirabilis on chromic catgut, polyglycolic acid and polyglactin 910: study in vitro.
    Hering FL; Rosenberg D; Chade J
    Urol Int; 1989; 44(4):231-4. PubMed ID: 2552634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains.
    Melendez-Avalos A; Sainz-Espuñes T; Castrillón-Rivera LE; Mendoza-Pérez F; Palma-Ramos A; Castañeda-Sánchez JI; Drago-Serrano EM
    Folia Microbiol (Praha); 2020 Feb; 65(1):133-142. PubMed ID: 31104302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin expression, enterocyte maturation, and bacterial internalization.
    Hess DJ; Henry-Stanley MJ; Moore EA; Wells CL
    J Surg Res; 2001 Jun; 98(2):116-22. PubMed ID: 11397127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on the adherence of Proteus mirabilis onto polymer surfaces.
    Stickler DJ; Lear JC; Morris NS; Macleod SM; Downer A; Cadd DH; Feast WJ
    J Appl Microbiol; 2006 May; 100(5):1028-33. PubMed ID: 16630003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic urinary tract infection in dogs: induction by inoculation with bacteria via percutaneous nephropyelostomy.
    Ling GV; Lowenstine LJ; Cullen JM; Ackerman N; Ruby AL
    Am J Vet Res; 1987 May; 48(5):794-8. PubMed ID: 3296890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.
    Cadieux PA; Chew BH; Knudsen BE; Dejong K; Rowe E; Reid G; Denstedt JD
    J Urol; 2006 Jun; 175(6):2331-5. PubMed ID: 16697868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
    Alamuri P; Mobley HL
    Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.